Aperio Group’s Edwards Lifesciences EW Stock Holding History

Aperio Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	$44.6M	Sell	488,596 -2,529	-0.5%	-$231K	0.13%	148
2020 Q3	$39.2M	Buy	491,125 +5,425	+1%	+$433K	0.13%	154
2020 Q2	$33.6M	Buy	485,700 +22,347	+5%	+$1.54M	0.12%	170
2020 Q1	$29.1M	Sell	463,353 -12,345	-3%	-$776K	0.13%	170
2019 Q4	$37M	Buy	475,698 +2,385	+0.5%	+$185K	0.13%	169
2019 Q3	$34.7M	Buy	473,313 +47,079	+11%	+$3.45M	0.14%	169
2019 Q2	$26.2M	Buy	426,234 +1,233	+0.3%	+$75.9K	0.11%	214
2019 Q1	$27.1M	Buy	425,001 +33,243	+8%	+$2.12M	0.12%	197
2018 Q4	$20M	Buy	391,758 +65,523	+20%	+$3.35M	0.1%	231
2018 Q3	$18.9M	Buy	326,235 +16,755	+5%	+$972K	0.08%	274
2018 Q2	$15M	Buy	309,480 +20,460	+7%	+$993K	0.07%	311
2018 Q1	$13.4M	Buy	289,020 +39,669	+16%	+$1.84M	0.07%	340
2017 Q4	$9.37M	Buy	249,351 +2,829	+1%	+$106K	0.05%	437
2017 Q3	$8.98M	Buy	246,522 +13,368	+6%	+$487K	0.05%	416
2017 Q2	$9.19M	Buy	233,154 +33,375	+17%	+$1.32M	0.06%	398
2017 Q1	$6.27M	Sell	199,779 -2,229	-1%	-$69.9K	0.04%	470
2016 Q4	$6.31M	Sell	202,008 -25,302	-11%	-$790K	0.05%	425
2016 Q3	$9.14M	Buy	227,310 +13,647	+6%	+$548K	0.07%	340
2016 Q2	$7.1M	Buy	213,663 +39,039	+22%	+$1.3M	0.06%	394
2016 Q1	$5.14M	Buy	174,624 +42,996	+33%	+$1.26M	0.04%	469
2015 Q4	$3.47M	Buy	131,628 +13,386	+11%	+$352K	0.03%	568
2015 Q3	$2.8M	Buy	118,242 +15,330	+15%	+$363K	0.03%	617
2015 Q2	$2.44M	Buy	102,912 +13,218	+15%	+$314K	0.03%	653
2015 Q1	$2.13M	Buy	89,694 +13,830	+18%	+$328K	0.02%	663
2014 Q4	$1.61M	Buy	75,864 +3,558	+5%	+$75.6K	0.02%	721
2014 Q3	$1.23M	Sell	72,306 -486	-0.7%	-$8.27K	0.02%	779
2014 Q2	$1.04M	Buy	72,792 +2,028	+3%	+$29K	0.02%	834
2014 Q1	$875K	Buy	+70,764	New	+$875K	0.01%	1069
2013 Q4	–	Sell	-69,618	Closed	-$808K	–	1078
2013 Q3	$808K	Buy	69,618 +31,908	+85%	+$370K	0.02%	929
2013 Q2	$422K	Buy	+37,710	New	+$422K	0.01%	1111